BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 475262)

  • 1. [Neutrophil polymorphonuclear chemotaxis in dermatology (author's transl)].
    Faure M
    Ann Dermatol Venereol; 1979 Feb; 106(2):115-23. PubMed ID: 475262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology of the polymorphonuclears in dermatology. Methods of investigation. Clinical pictures (author's transl)].
    de Prost Y; Touraine R
    Ann Dermatol Venereol; 1979 Feb; 106(2):109-12. PubMed ID: 224753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutrophil chemotaxis and its role in the pathogenesis of dermatoses].
    Skripkin IuK; Lezvinskaia EM
    Vestn Dermatol Venerol; 1986; (6):31-7. PubMed ID: 3019036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary disorders of neutrophils: principal clinical and laboratory aspects].
    Bellinati-Pires R; Araújo MI; Carneiro-Sampaio MM
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(2):79-88. PubMed ID: 1340018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulated neutrophil locomotion: chemokinesis and chemotaxis.
    Becker EL
    Arch Pathol Lab Med; 1977 Oct; 101(10):509-13. PubMed ID: 199132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of leukotaxis in neutrophils and monocytes].
    Morenz J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):153-92. PubMed ID: 69580
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.
    Quie PG; Cates KL
    Am J Pathol; 1977 Sep; 88(3):711-26. PubMed ID: 407800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical defects of neutrophil chemotaxis].
    Lisiewicz
    Wiad Lek; 1978 Mar; 31(6):395-8. PubMed ID: 349893
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of complement anaphylatoxins in neutrophil arachidonic acid metabolism.
    Clancy RM; Hugli TE
    Prog Clin Biol Res; 1985; 199():173-84. PubMed ID: 2999821
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotaxis in cutaneous disease.
    Dahl MV
    Int J Dermatol; 1978 Mar; 17(2):95-104. PubMed ID: 348618
    [No Abstract]   [Full Text] [Related]  

  • 11. Mice deficient in C5.
    Rosenberg LT; Tachibana DK
    Prog Allergy; 1986; 39():169-91. PubMed ID: 3562463
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neutrophils: their significance and function].
    Kowal E; Tarasiewicz F
    Pol Tyg Lek; 1977 Jul; 32(30):1175-7. PubMed ID: 142973
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of neutrophil function: an overview.
    Dinauer MC
    Methods Mol Biol; 2007; 412():489-504. PubMed ID: 18453130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophil chemotaxis. II. Clinical implications and therapeutic indications in children].
    Cazzola GA; Valletta EA; Cipolli M
    Pediatr Med Chir; 1990; 12(1):25-31. PubMed ID: 2198548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: complement diseases in man.
    Miller ME
    Birth Defects Orig Artic Ser; 1975; 11(1):299-300. PubMed ID: 1148384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Granulocytic phagocytosis disorders. Basis and diagnosis].
    Rister M
    Dtsch Med Wochenschr; 1979 Oct; 104(43):1535-9. PubMed ID: 387365
    [No Abstract]   [Full Text] [Related]  

  • 19. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
    Ballow M; Fang F; Good RA; Day NK
    Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.
    Clark RA; Kimball HR
    J Clin Invest; 1971 Dec; 50(12):2645-52. PubMed ID: 4942966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.